Informazioni sul prodotto
- 1H-Pyrido[4,3-b]indole, 2,3,4,5-tetrahydro-2-methyl-5-(phenylmethyl)-
- 1H-Pyrido[4,3-b]indole, 5-benzyl-2,3,4,5-tetrahydro-2-methyl-
- 2,3,4,5-Tetrahydro-2-methyl-5-(phenylmethyl)-1H-pyrido[4,3-b]indole
- 2H-Pyrido[4,3-b]indole, 5-benzyl-1,3,4,5-tetrahydro-2-methyl-
- 3-Methyl-9-benzyl-1,2,3,4-tetrahydro-γ-carboline
- 5-Benzyl-1,2,3,4-Tetrahydro-2-Methylpyrido(4,3-B)Indole
- 5-Benzyl-1,2,3,4-tetrahydro-2-methyl-γ-carboline
- 5-Benzyl-1,3,4,5-tetrahydro-2-methyl-2H-pyrido[4,3-b]indole
- 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-2-ium
- 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
- Vedi altri sinonimi
- N-Methyl-9-benzyltetrahydro-γ-carboline
- naphthalene-1,5-disulfonic acid - 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole (1:1)
Mebhydrolin is a drug used to treat metabolic disorders and symptoms such as hyperglycemia, hyperlipidemia, and hyperuricemia. It is also used for the treatment of autoimmune diseases, such as rheumatoid arthritis. Mebhydrolin inhibits potassium dichromate-induced dopamine release in rat brain synaptosomes. The clinical relevance of this effect is not clear. Mebhydrolin has been shown to have no toxicological effects on the bowel and may be beneficial in bowel disease because it stimulates sodium citrate absorption. In addition, mebhydrolin has been shown to inhibit inflammatory bowel disease by blocking the 5HT3 receptor activity in animal studies.
Proprietà chimiche
Richiesta tecnica su: 3D-AAA52481 Mebhydrolin
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
